Among the 520 patients with early-stage colorectal cancer (Fig. 3a), NNMT overexpression was significantly associated with both shorter overall and disease-free survival (p = 0.0056 and p = 0.0260, respectively). The gene discussed is NNMT; the disease is colorectal cancer.